Daniel Schneeberger serves as Executive at Keros Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Daniel Schneeberger has executed 3 insider transactions totaling $95.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 15, 2025 involved selling 743,358 shares valued at $13.2M.
Daniel Schneeberger currently holds 0 shares of Keros Therapeutics, Inc. (KROS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Schneeberger has been a net seller of KROS stock. They have purchased $0 and sold $95.7M worth of shares.
Daniel Schneeberger's most recent insider trade was on Oct 15, 2025, when they sold 743,358 shares at $17.75 per share.
Get notified when new Form 4 filings are submitted
| $17.75 |
| Discretionary |
| Oct 15, 2025 | KROS | $4.5M | Sale | 254,669 | $17.75 | Discretionary |